methotrexate

The drug is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis and psoriatic arthritis, as well as for the therapy of Crohn's disease.

Form: solution for injection

ATC: L04AX03

Manufacturer: Medak Gesellschaft fuer klinische Spezialpraparate mbH (manufacturer responsible for secondary packaging; manufacturer responsible for secondary packaging, labeling, control/testing of batch and batch release)

It is used for antirheumatic therapy (e.g., for rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent in acute leukemia.

Form: tablets

ATC: L04AX03 L01BA01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

It is used for antirheumatic therapy (for example, in rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent during maintenance therapy for acute leukemia.

Form: tablets

ATC: L04AX03 L01BA01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used for anti-rheumatic therapy (e.g., for rheumatoid arthritis), for the treatment of severe forms of psoriasis, and as a cytostatic agent in maintenance therapy for acute leukemia.

Form: tablets

ATC: L04AX03 L01BA01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used to treat rheumatoid arthritis, psoriasis (particularly the plaque type), psoriatic arthritis, as well as for the therapy of certain types of cancer (e.g., breast cancer, non-Hodgkin lymphoma, acute lymphoblastic leukemia, and malignant trophoblastic tumors).

Form: solution for injection

ATC: L01BA01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used to treat adults and children from 3 years of age for various oncological diseases, including malignant tumors, breast cancer, head and neck cancer, non-Hodgkin lymphoma, and acute lymphoblastic leukemia. It is also used for the prevention and treatment of carcinomatous meningitis.

Form: concentrate for infusion solution

ATC: L01BA01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used to treat various types of tumors (e.g., leukemia, osteosarcoma, lymphoma, breast cancer), as well as for the therapy of severe forms of psoriasis and rheumatoid arthritis.

Form: solution for injection

ATC: L01BA01

Manufacturer: Farmakhem B.V. (full-cycle manufacturing)

The drug is used to treat various types of cancer (e.g., leukemia, osteosarcoma, lymphoma, breast cancer), trophoblastic tumors, as well as severe forms of psoriasis and rheumatoid arthritis.

Form: solution for injection

ATC: L01BA01

Manufacturer: Farmakhem B.V. (full-cycle manufacturing)

The drug is used to treat active rheumatoid arthritis in adults, severe forms of psoriasis and psoriatic arthritis, as well as to treat polyarticular forms of juvenile idiopathic arthritis in children and adolescents from 3 years of age.

Form: solution for injection

ATC: L04AX03

Manufacturer: K.T. ROMFARM COMPANY S.R.L. (manufacturing medicinal product, aseptic filling of medicinal product into syringes, their assembly and labeling; control of raw materials, control of physico-chemical parameters of intermediate and final product, batch release; secondary packaging, control of microbiological and biological parameters of medicinal product)

It is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute leukemia.

Form: tablets

ATC: L01BA01 L04AX03

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for primary packaging labeling, secondary packaging, control/testing of batch and batch release)

The drug is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute leukemia.

Form: tablets

ATC: L01BA01 L04AX03

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for primary packaging labeling, secondary packaging, control/testing of batch and batch release)

The drug is used for the treatment of active rheumatoid arthritis in adults, severe forms of psoriasis (especially the plaque type), as well as for maintenance therapy of acute lymphoblastic leukemia.

Form: tablets

ATC: L01BA01 L04AX03

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for primary packaging labeling, secondary packaging, control/testing of batch and batch release)

The drug is used to treat the active form of rheumatoid arthritis in adults, severe forms of psoriasis and psoriatic arthritis, as well as for the therapy of Crohn's disease (in cases where other treatments are ineffective). It is also prescribed to children from 3 years of age for the polyarticular form of juvenile idiopathic arthritis.

Form: solution for injection

ATC: L01BA01

Manufacturer: Onko Ilac Sanayi ve Ticaret A.S.